Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Alesta Therapeutics

Tracked across 1 events · 6 articles · First seen Aug 19, 2026 · Last active Sep 02, 2026

Sentiment
70
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Business
Impact: Alesta is the acquired company, now a wholly owned subsidiary of BioMarin. The acquisition provides a significant return for its shareholders and validates its lead asset ALE1, though its employees and non-ALE1 assets were spun out.
Aug 19, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Alesta Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.